I’m stunned by the extremes to which a pharmaceutical company will go when attempting to get FDA approval for some new drug. Take a look at the latest offering from privately-held Sprout Pharmaceuticals, who claim they now have a “female Viagra.” Yes, really. It is called Addyi. This drug is potentially dangerous, with some frightening side effects. They include an increased risk of syncope—temporary loss of consciousness—as well as severe low blood sugar, insomnia, dry mouth, fatigue, dizziness, sedation, and anxiety. Manufacturers warn if you decide to use it, not to drink alcohol. I wouldn’t touch Addyi with a ten foot pole.
Addyi is actually Flibanserin—a failed antidepressant. Unlike Viagra, which is designed to bring more blood flow to male genitals if a man chooses to use it temporarily, Addyi is supposed to be used every day—long-term by women. It claims to enhance a woman’s sexual impulses by targeting, not your genitals but your brain. Flibanserin is similar to other selective serotonin reuptake inhibitors (SSRIs) like Prozac. Ironically these drugs are notorious not for increasing libido, but for blunting it. Some time ago, Big Pharma invented a whole new “illness” known as Hypoactive Sexual Desire Disorder, defined as “persistently or recurrently deficient (or absent) sexual fantasies and desire for sexual activity.” Addyi is supposed to treat this.
Originally developed by family-owned Boehringer Ingelheim in Germany Flibanserin, after lengthy trails was judged to be ineffective as an antidepressant. Boehringer had submitted this drug to the FDA for approval in 2011. It was refused. Out of 1300 women who took part in trials, 15% dropped out due to unpleasant side effects. The FDA rejected the appeal, saying that whatever the drugs drug’s minor benefits might be they could not justify its nasty side effects. So Boehringer sold their invention to Sprout Pharmaceuticals in 2011. Who tried their luck with the FDA in 2013 and also got nowhere. However, Sprout’s persistence, massive lobbying and and financial investments amassed more than 60,000 supporting signatures so finally won FDA’s approval for the drug in August of 2015. This FDA approval stands next to many other applications which have won FDA approval in the past, showing that, when companies spend enough money, they can, in effect, force the FDA to approve many useless or dangerous drugs.
Adriane Fugh-Berman MD, Pharmacology Professor at Georgetown University, describes Addyi as "a mediocre aphrodisiac with scary side-effects.” She adds, “The only thing that’s different is a clever, aggressive public relations campaign that Sprout Pharmaceuticals waged successfully.”
Meanwhile, the outspoken Dr Mark Sircus makes his own assessment of the situation, which is well worth listening to. Sircus says, “Most doctors and medical associations just do not get that women are different from men sexually. They do not have genitals that function independent of their hearts and minds. The feminine principle is pretty much dead in modern civilization and especially at the FDA, which runs like the SS, a medical Gestapo. The FDA again proves what type of organization it is exposing women in America to the dangers and horrors of pharmaceutical drugs. They are the most unnatural organization in the world poisoning people instead of helping.” Need I say more?
If you want to learn about safe natural aphrodisiacs that not only work but are a delight to use, I’ll be covering some of my favorites on our next two videocasts. Look forward to seeing you then.